Cencora Q2 2021 Earnings Report
Key Takeaways
AmerisourceBergen reported a solid performance in the March quarter, with revenue increasing by 3.7% year-over-year to $49.2 billion. The company's adjusted diluted EPS increased by 5.4% to $2.53, and the adjusted diluted EPS guidance for fiscal year 2021 has been raised to a range of $8.45 to $8.60.
Revenue increased 3.7 percent year-over-year to $49.2 billion.
GAAP diluted EPS was $2.10, compared to $4.64 in the prior year quarter.
Adjusted diluted EPS increased 5.4 percent to $2.53.
Adjusted diluted EPS guidance raised to $8.45 to $8.60 for fiscal 2021.
Cencora
Cencora
Forward Guidance
AmerisourceBergen has updated its fiscal year 2021 financial guidance to reflect the Company’s continued strong performance, including better than expected performance in our Global Commercialization Services & Animal Health group, and an incrementally higher expected share count for the year.
Positive Outlook
- Adjusted Diluted EPS to be in the range of $8.45 to $8.60, raised from the previous range of $8.40 to $8.60.
- Adjusted operating expense growth in the high-single digit percent range, narrowed from the mid- to high-single digit percent range.
- Other, which is comprised of our Global Commercialization Services & Animal Health businesses, operating income growth in the low-double digit percent range, up from the mid- to high-single digit percent range.
- Weighted average shares to be between 207 million and 208 million, raised from the previous expectation of approximately 207 million for the fiscal year.
- All other previously communicated aspects of the Company's fiscal year 2021 financial guidance and assumptions remain the same.